v3.25.2
Redeemable Convertible Preferred Stock, Redeemable Common Stock, and Stockholders Equity (Deficit) (Q2) (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Equity [Abstract]    
Schedule of temporary equity

As of December 31, 2024, the Company had five classes of redeemable convertible preferred stock, which consisted of the following (in thousands, except per share amounts):

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares
Authorized
 
 
Shares
Issued and
Outstanding
 
 
Issuance
Price
Per Share
 
 
Carrying
Value
 
 
Aggregate
Liquidation
Preference
Series Seed
 
 
60,000
 
 
45,567
 
 
$0.05
 
 
$2,039
 
 
$2,039
Series A
 
 
24,182
 
 
19,361
 
 
0.12
 
 
2,256
 
 
2,256
Series B
 
 
79,979
 
 
79,979
 
 
5.58
 
 
550,595
 
 
446,002
Series B-1
 
 
12,485
 
 
10,205
 
 
0.40
 
 
4,091
 
 
4,091
Series C
 
 
29,523
 
 
29,523
 
 
38.95
 
 
1,163,130
 
 
1,163,671
Total
 
 
206,169
 
 
184,635
 
 
 
 
$1,722,111
 
 
$1,618,059
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

As of December 31, 2023 and 2024, the Company had four and five classes of redeemable convertible preferred stock, respectively. As of December 31, 2023, redeemable convertible preferred stock consisted of the following (in thousands, except per share amounts):

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares
Authorized
 
 
Shares
Issued and
Outstanding
 
 
Issuance
Price
Per Share
 
 
Carrying
Value
 
 
Aggregate
Liquidation
Preference
Series Seed
 
 
60,000
 
 
48,896
 
 
$0.05
 
 
$2,205
 
 
$2,205
Series A
 
 
24,182
 
 
19,879
 
 
0.12
 
 
2,316
 
 
2,316
Series B
 
 
79,979
 
 
75,496
 
 
5.58
 
 
455,996
 
 
421,001
Series B-1
 
 
12,485
 
 
10,407 
 
 
0.40
 
 
4,173
 
 
4,173
Total
 
 
176,646
 
 
154,678
 
 
 
 
 
$464,690
 
 
$429,695
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

As of December 31, 2024, redeemable convertible preferred stock consisted of the following (in thousands, except per share amounts):

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shares
Authorized
 
 
Shares
Issued and
Outstanding
 
 
Issuance
Price
Per Share
 
 
Carrying
Value
 
 
Aggregate
Liquidation
Preference
Series Seed
 
 
60,000
 
 
45,567
 
 
$0.05
 
 
$2,039
 
 
$2,039
Series A
 
 
24,182
 
 
19,361
 
 
0.12
 
 
2,256
 
 
2,256
Series B
 
 
79,979
 
 
79,979
 
 
5.58
 
 
550,595
 
 
446,002
Series B-1
 
 
12,484
 
 
10,205
 
 
0.40
 
 
4,091
 
 
4,091
Series C
 
 
29,523
 
 
29,523
 
 
38.95
 
 
1,163,130
 
 
1,163,671
Total
 
 
206,169
 
 
184,635
 
 
 
 
 
$1,722,111
 
 
$1,618,059
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schedule of stock options activity

The following table summarizes stock option activity under the 2019 Plan (share data and aggregate intrinsic value in thousands):

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock
Options
Outstanding
 
 
Weighted-
Average
Exercise Price
 
 
Weighted-
Average
Remaining
Contractual
Term
(Years)
 
 
Aggregate
Intrinsic Value
Balance at January 1, 2025
 
 
47,219
 
 
$1.74
 
 
7
 
 
$2,163,455
Granted
 
 
—
 
 
—
 
 
 
 
 
 
Exercised
 
 
(2,950)
 
 
1.53
 
 
 
 
 
 
Forfeited, expired, or canceled
 
 
(164)
 
 
6.62
 
 
 
 
 
 
Outstanding at June 30, 2025
 
 
44,105
 
 
$1.74
 
 
7
 
 
$7,114,827
Vested and expected to vest at June 30, 2025
 
 
44,105
 
 
$1.74
 
 
7
 
 
$7,114,827
Exercisable at June 30, 2025
 
 
31,596
 
 
$1.14
 
 
6
 
 
$5,116,131
 
 
 
 
 
 
 
 
 
 
 
 
 

The following table summarizes stock option activity under the Plan (share data and aggregate intrinsic value in thousands):

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock
Options
Outstanding
 
 
Weighted-Average
Exercise Price
 
 
Weighted-Average
Remaining
Contractual
Term (Years)
 
 
Aggregate
Intrinsic Value
Balance at January 1, 2023
 
 
32,655
 
 
$0.33
 
 
8
 
 
$20,770
Granted
 
 
23,300
 
 
3.48
 
 
 
 
 
 
Exercised
 
 
(4,337)
 
 
0.38
 
 
 
 
 
 
Forfeited, expired, or canceled
 
 
(379)
 
 
1.70
 
 
 
 
 
 
Outstanding at December 31, 2023
 
 
51,239
 
 
$1.75
 
 
8
 
 
$795,013
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
 
 
—
 
 
—
 
 
 
 
 
 
Exercised
 
 
(2,872)
 
 
1.01
 
 
 
 
 
 
Forfeited, expired, or canceled
 
 
(1,148)
 
 
4.05
 
 
 
 
 
 
Outstanding at December 31, 2024
 
 
47,219
 
 
$1.74
 
 
7
 
 
$2,163,455
Vested and expected to vest at December 31, 2023
 
 
51,239
 
 
$1.75
 
 
8
 
 
$795,013
Vested and expected to vest at December 31, 2024
 
 
47,219
 
 
$1.74
 
 
7
 
 
$2,163,455
Exercisable at December 31, 2023
 
 
24,356
 
 
$0.37
 
 
6
 
 
$411,567
Exercisable at December 31, 2024
 
 
31,019
 
 
$0.98
 
 
6
 
 
$1,444,794
 
 
 
 
 
 
 
 
 
 
 
 
 
Schedule of restricted stock unit activity

RSUs granted typically vest over four years. The following table summarizes restricted stock unit activity under the 2019 and 2025 Plans (share data in thousands):

 
 
 
 
 
 
 
 
 
 
Shares
 
 
Weighted-
Average Fair
Value Per Share
Balance at January 1, 2025
 
 
15,455
 
 
$38.80
Granted
 
 
13,188
 
 
62.39
Vested
 
 
(2,599)
 
 
33.36
Forfeited, expired, or canceled
 
 
(367)
 
 
36.57
Unvested balance at June 30, 2025
 
 
25,677
 
 
$51.50
Vested and not yet settled
 
 
9
 
 
45.96
Outstanding at June 30, 2025
 
 
25,686
 
 
$51.50
 
 
 
 
 
 
 

RSUs granted typically vest over four years. The following table summarizes restricted stock unit activity under the Plan for the year ended December 31, 2024 (share data in thousands):

 
 
 
 
 
 
 
 
 
 
Shares
 
 
Weighted-
Average Fair
Value Per Share
Balance at January 1, 2024
 
 
—
 
 
$—
Granted
 
 
 15,733
 
 
38.56
Vested
 
 
—
 
 
—
Forfeited, expired, or canceled
 
 
(278)
 
 
25.18
Unvested balance at December 31, 2024
 
 
15,455
 
 
$38.80
 
 
 
 
 
 
 
Schedule of stock-based compensation expense

Total stock-based compensation expense recognized in the Company’s condensed consolidated statements of operations was as follows (in thousands):

 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30,
 
 
Six Months Ended June 30,
 
 
 
2025
 
 
2024
 
 
2025
 
 
2024
Cost of revenue
 
 
$2,701
 
 
$350
 
 
$5,394
 
 
$738
Technology and infrastructure
 
 
47,683
 
 
2,080
 
 
102,282
 
 
4,437
Sales and marketing
 
 
8,494
 
 
848
 
 
11,314
 
 
1,715
General and administrative
 
 
86,127
 
 
4,382
 
 
209,988
 
 
8,959
Total stock-based compensation expense(1)(2)
 
 
$145,005
 
 
$7,660
 
 
$328,978
 
 
$15,849
 
 
 
 
 
 
 
 
 
 
 
 
 

Total stock-based compensation expense recognized in the Company’s consolidated statements of operations was as follows (in thousands):

 
 
 
 
 
 
 
Year Ended
December 31,
 
 
 
2022
 
 
2023
 
 
2024
Cost of revenue
 
 
$133
 
 
$694
 
 
$1,307
Technology and infrastructure
 
 
624
 
 
7,100
 
 
10,137
Sales and marketing
 
 
74
 
 
1,740
 
 
3,408
General and administrative
 
 
659
 
 
5,620
 
 
16,635
Total stock-based compensation expense
 
 
$1,490
 
 
$15,154
 
 
$31,487